EOC Pharma Group Company Profile

EOC is a fast-growing, Shanghai-based biopharmaceutical company that is
focused on the in-licensing of innovative global oncology products, and
developing, manufacturing and commercializing them for the China market.
The Company is building a fully integrated manufacturing, development
and commercialization platform, and has a pipeline of six novel products
from global biopharmaceutical partners that are potentially first- and
best-in-class. EOC is a spin-off of the oncology division of
Eddingpharm, a leading specialty pharmaceutical company in China that is
dedicated to in-licensing, marketing and commercializing branded drugs
from global pharmaceutical companies.

China Resources Pharma will pay $667 million to acquire all the outstanding shares of Jiangzhong Pharma, a listed company. Three weeks ago, CR Pharma announced plans to acquire a stake in the parent c...

Self-control emerges in a rich sociocultural context. Do group norms around self-control influence the degree to which children use it? We tested this possibility by assigning 3- to 5-year-old childre...

In recent years, chimeric antigen receptor (CAR) modified T cells have been used as a treatment for haematological malignancies in several phase I and II trials and with Kymriah of Novartis and Yescar...

SK group, serving the pharma industry with dedication since 1932, has a proven track record and expertise in manufacturing, importing, exporting & distribution of Bulk Drugs, Fine Chemicals and Pharma...

Fournier Pharma has been acquired by the Solvay Group in July 2005.Solvay is an international chemicals and pharmaceuticals group with headquarters in Brussels. It is present in more than 50 countries...

Relevant Topics

Collaborations in biotechnologyCommercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development.
Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc.
...